Jacob Donoghue is the Co-Founder and CEO of Beacon Biosignals, a company using an AI platform for EEG to develop new treatments for neurological diseases. He earned his MD from Harvard Medical School and a PhD from MIT, combining medical expertise with deep technical knowledge to advance brain health.
Driven by a mission to improve patient lives, Jacob is focused on bringing precision medicine to the field of neurology. His work involves translating complex scientific research into tangible clinical solutions, aiming to make a lasting impact for those with serious disorders of the brain.
Jacob was recently named to BioSpaces "40 Under 40 in Biopharma for 2025" for his leadership in healthcare innovation.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.